MyFinsight
Home
Blog
About
Back
Income Statement
Tarsus Pharmaceuticals, Inc. (TARS)
Tarsus Pharmaceuticals, Inc. (TARS)
source: myfinsight.com
Comprehensive loss
-$18,810K
(7.73%↑ Y/Y)
Interest income
$3,698K
(-12.56%↓ Y/Y)
Gain on exchange of
long-term investments
$2,812K
Net loss
-$18,551K
(8.80%↑ Y/Y)
Unrealized gain (loss) on
marketable securities and...
-$259K
(-463.04%↓ Y/Y)
Total other income
(expense), net
$4,073K
(120.88%↑ Y/Y)
Product
$173,912K
(69.41%↑ Y/Y)
Interest expense
$2,156K
(-3.75%↓ Y/Y)
Other income
(expense), net
-$281K
(-93.79%↓ Y/Y)
Loss from operations
before other income...
-$19,908K
(10.26%↑ Y/Y)
total revenues
$173,912K
(69.41%↑ Y/Y)
Provision for income taxes
$2,716K
Total operating
expenses
$193,820K
(55.25%↑ Y/Y)
Back